Please login to the form below
Gavin Giovannoni
This page shows the latest Gavin Giovannoni news and features for those working in and with pharma, biotech and healthcare.
Merck Serono's MS drug approved in Russia
We expect other regulatory approvals in the near future.". Gavin Giovannoni of the UK's Blizard Institute of Cell and Molecular Science and principal investigator of CLARITY, said the approval will
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
The role of brain health in treating MS
Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the ... Rather than treating and reducing relapses, top
-
Blue Latitude Health
Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- Bedrock Group rebrands as Resonant Group
- Lucid Group Bolster its Senior Leadership Team
- FDA approves Roche’s Actemra COVID-19 trial
- Keytruda shows significant and meaningfully improvement in kidney cancer
- WHITE PAPER: Why do men die younger?
- Opdivo improves survival in oesophageal cancer
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
Quick links
Infographics
